锝 Tc 99m 甲氧基异丁基异腈心肌灌注显像：评估预后的当前作用
Technetium Tc 99m sestamibi myocardial perfusion imaging: current role for evaluation of prognosis.
作者信息
Mandalapu B P, Amato M, Stratmann H G
机构信息
Department of Cardiology, St. Louis Veterans Administration Medical Center, MO 63106, USA.
出版信息
Chest. 1999 Jun;115(6):1684-94. doi: 10.1378/chest.115.6.1684.
Like 201Tl imaging, technetium Tc 99m sestamibi (MIBI) myocardial imaging can be used with exercise and pharmacologic testing to assess the presence of coronary artery disease. An increasing body of literature indicates that MIBI can also be used to assess risk of future cardiac events such as myocardial infarction or death. This article summarizes the current status of MIBI imaging for evaluating prognosis in patients with known or suspected coronary artery disease.
与铊 201 成像一样，锝 Tc 99m 甲氧基异丁基异腈（MIBI）心肌成像可与运动及药物试验一起用于评估冠状动脉疾病的存在情况。越来越多的文献表明，MIBI 还可用于评估未来心脏事件（如心肌梗死或死亡）的风险。本文总结了 MIBI 成像在评估已知或疑似冠状动脉疾病患者预后方面的现状。
Zotero 插件